Evaluating Efficacy and Safety of Tofersen in Adults with SOD1-ALS: Results from the Phase 3 VALOR Trial and Open-Label Extention - Miller, TMC M; Genge, A; Shaw, P J; Sobue, G; Cochrane, T; Nestorov, I; Graham, D; Sun, P; McNeill, M; Fanning, L; Ferguson, T A; Fradette, S (European Network for the Cure of Amyotrophic Lateral Sclerosis – 20th Meeting June 2022, 2022)
on behalf of the VALOR and OLE Working Group